Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 11 Sep 2023
Australia: A reduced incidence of cancer may be linked to three to four minutes of vigorous intermittent lifestyle physical activity (VILPA).
Read Full NewsSwiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin.
Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.
Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.
An observational study suggests that bone mineral density may serve as a marker of systemic health.
Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.
Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.
1.
NIH research cuts leave cancer patient facing hard choice
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI
4.
Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery
5.
New surgical method shows promising results for cervical cancer treatment
1.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
2.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
3.
Different Types of Blood Dyscrasias
4.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
5.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge